Literature DB >> 19142890

A cost effectiveness analysis of omitting radiography in diagnosis of acute bronchiolitis.

Jean Hai Ein Yong1, Suzanne Schuh, Rasha Rashidi, Sonia Vanderby, Rodney Lau, Audrey Laporte, Eric Nauenberg, Wendy J Ungar.   

Abstract

OBJECTIVE: To carry out a cost-effectiveness analysis of omitting chest radiography in the diagnosis of infant bronchiolitis. HYPOTHESIS: Omitting chest radiographs in the diagnosis of typical bronchiolitis was expected to reduce costs without adversely affecting the detection rate of alternate diseases. STUDY
DESIGN: An economic evaluation was conducted using clinical and health resources. Emergency department (ED) physicians provided diagnoses pre- and post-radiography as well as a management plan. The primary outcome was the diagnostic accuracy (false-negative rate) of alternate diagnoses with and without X-ray. The incremental costs of omitting radiography in comparison to routine radiography per patient were assessed from a health system perspective. PATIENT SELECTION: We studied 265 infants, 2-23 months old, presenting at the ED with typical bronchiolitis. Patients with pre-existing conditions or radiographs were omitted from the study.
METHODOLOGY: Expected costs to the health care system of including and excluding chest radiographs were compared, including costs associated with misdiagnosis.
RESULTS: All alternate diagnoses (two cases) were missed by ED physicians pre- and post-radiography, resulting in a 100% false negative rate. The specificity in detecting alternate diseases was 96.6% pre-radiography and 88.6% post-radiography. Of the 17 cases of coexistent pneumonia, 88% were missed pre-radiography and 59% post-radiography, with respective false positive rates of 10.5% and 16.1%. Omission of routine chest radiograph saved CDN $59 per patient, primarily due to savings in radiography and hospitalization costs. The economic benefit persisted after the inpatient length of stay, ED overhead and radiograph costs were varied.
CONCLUSION: For infants with typical bronchiolitis, omitting radiography is cost saving without compromising diagnostic accuracy of alternate diagnoses and of associated pneumonia. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19142890     DOI: 10.1002/ppul.20948

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

1.  Adherence of Spanish pediatricians to "do not do" guidelines to avoid low-value care in pediatrics.

Authors:  Roi Piñeiro-Pérez; Carlos Ochoa-Sangrador; David López-Martín; Leticia Martínez-Campos; Cristina Calvo-Rey; Bruno José Nievas-Soriano
Journal:  Eur J Pediatr       Date:  2022-09-14       Impact factor: 3.860

2.  Antibiotic prescribing pattern in paediatric in patients with first time wheezing.

Authors:  Soumya Patra; Varinder Singh; Harish K Pemde; Jagdish Chandra
Journal:  Ital J Pediatr       Date:  2011-09-05       Impact factor: 2.638

3.  Cost-effectiveness analysis for clinicians.

Authors:  Suzanne R Hill
Journal:  BMC Med       Date:  2012-02-01       Impact factor: 8.775

4.  Impact of chest radiography for children with lower respiratory tract infection: a propensity score approach.

Authors:  Emmanuelle Ecochard-Dugelay; Muriel Beliah; Caroline Boisson; Francis Perreaux; Jocelyne de Laveaucoupet; Philippe Labrune; Ralph Epaud; Hubert Ducou-Lepointe; Jean Bouyer; Vincent Gajdos
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

5.  Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis.

Authors:  Paola Papoff; Corrado Moretti; Giulia Cangiano; Enea Bonci; Mario Roggini; Alessandra Pierangeli; Carolina Scagnolari; Guido Antonelli; Fabio Midulla
Journal:  Acta Paediatr       Date:  2011-03-01       Impact factor: 2.299

6.  Understanding factors that contribute to variations in bronchiolitis management in acute care settings: a qualitative study in Australia and New Zealand using the Theoretical Domains Framework.

Authors:  Libby Haskell; Emma J Tavender; Catherine Wilson; Franz E Babl; Ed Oakley; Nicolette Sheridan; Stuart R Dalziel
Journal:  BMC Pediatr       Date:  2020-05-01       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.